Jump to main content
Jump to site search

Issue 16, 2012
Previous Article Next Article

Dendrimer-mediated drug delivery to the skin

Author affiliations

Abstract

Nanoparticles have been increasingly used as carriers for local and systemic drug delivery via the skin. Dendrimers are emerging as the new generation of nanocarriers in skin drug delivery mainly due to their small size, extreme molecular uniformity, and highly functional surfaces. Despite the abundance of investigations which demonstrate the dendrimer-mediated skin delivery enhancement both in vitro and in vivo, there are still controversies over the mechanisms of their action. Based on the critical analysis of currently available data in this field, it is found that the skin delivery enhancement by dendrimers depends on the drug–dendrimer–skin interactions and three potential mechanisms are proposed. Firstly, for some drugs, dendrimers may act as a drug release modifier and speed up the drug dissolution that is the rate-limiting step of percutaneous drug absorption. Secondly, via particle engineering the properties of dendrimers can be tailored to preferably penetrate the skin via the follicular route. Finally, certain low generation dendrimers may impair the stratum corneum barrier function, particularly in the presence of potent vehicles.

Graphical abstract: Dendrimer-mediated drug delivery to the skin

Back to tab navigation

Publication details

The article was received on 01 Dec 2011, accepted on 05 Jan 2012 and first published on 31 Jan 2012


Article type: Opinion
DOI: 10.1039/C2SM07280G
Citation: Soft Matter, 2012,8, 4301-4305

  •   Request permissions

    Dendrimer-mediated drug delivery to the skin

    M. Sun, A. Fan, Z. Wang and Y. Zhao, Soft Matter, 2012, 8, 4301
    DOI: 10.1039/C2SM07280G

Search articles by author

Spotlight

Advertisements